Turkiye Klinikleri Journal of Health Sciences

.: REVIEW
Kronik Obstrüktif Akciğer Hastalığında D Vitamininin Rolü
The Role of Vitamin D in Chronic Obstructive Pulmonary Disease
Fatmanur Hümeyra ZENGİNa, Makbule GEZMEN KARADAĞb
aBeslenme ve Diyetetik Bölümü, Sağlık Bakanlığı Ankara Eğitim ve Araştırma Hastanesi,
bBeslenme ve Diyetetik Bölümü, Gazi Üniversitesi Sağlık Bilimleri Fakültesi, Ankara, TÜRKİYE
Turkiye Klinikleri J Health Sci. 2019;4(3):323-32
doi: 10.5336/healthsci.2018-64068
Article Language: TR
Full Text
ÖZET
 Kronik obstrüktif akciğer hastalığı (KOAH) önemli bir halk sağlığı sorunudur ve dünya çapında morbidite ve mortalitenin ana nedenlerinden biridir. Dünya Sağlık Örgütü'nün verilerine göre; KOAH bulaşıcı olmayan hastalıklar arasında dünyadaki ölümlerin ve engelliliğe ayarlanmış yaşam yılının en önemli üç nedeninden biridir. Son zamanlarda yapılan çalışmalar KOAH'lı bireylerin kontrol grubundan daha yüksek D vitamini eksikliği prevalansına sahip olduklarını ve D vitamini eksikliğinin; akciğer fonksiyonlarında ve immünitede azalma ve inflamasyonda artış ile ilişkili olduğunu göstermektedir. D vitamini metabolizmasının KOAH patofizyolojisine nasıl bağlı olabileceğinin altında yatan mekanizmalar genellikle karmaşıktır ve tam olarak anlaşılamamıştır. D vitamini; uzun yıllardır bilinen kalsemik etkilerinin yanında, daha az bilinen antimikrobiyal, immünolojik, havayolu yeniden yapılanması ve epigenetik regülasyon gibi nonkalsemik etkileri ile de KOAH'da önemli bir yere sahiptir. Ayrıca, iskelet kası gücü ve inhale kortikosteroid kullanımı üzerine etkileri de son yıllarda dikkat çekmektedir. Henüz D vitamini ile KOAH arasındaki ilişki belirsiz olsa da D vitamini yetersizliği ile KOAH patogenezi, progresyon, alevlenmeler ve komorbiditeler arasındaki olası ilişki, D vitamini takviyesinin KOAH'ta yararlı olabileceğini düşündürmektedir. Ancak, D vitamini takviyesi birçok çalışmada KOAH'lı bireylere ek yarar sağlamamış, sadece şiddetli D vitamini eksikliği olan hastalarda alevlenme azalması bildirilmiştir. Bu çalışmada, epidemiyolojik bulgulara ve altta yatan mekanizmalara odaklanılarak KOAH'ta D vitaminin rolü hakkında bilimsel literatürü gözden geçirmek amaçlanmıştır.

Anahtar Kelimeler: KOAH; D vitamini; VDR; akciğer hastalıkları; inflamasyon
ABSTRACT
 Chronic obstructive pulmonary disease (COPD) is an important public health problem and one of the main causes of morbidity and mortality worldwide. According to data from the World Health Organization; COPD is one of the three most important causes of death and disability-adjusted life-year among noncommunicable diseases in the world. Recent studies have shown that individuals with COPD have vitamin D deficiency and also vitamin D deficiency are associated with decreased lung function and immunity and increased inflammation. The mechanisms underlying how vitamin D metabolism may be linked to the pathophysiology of COPD are often complex and not fully understood. Vitamin D; has an important place in COPD with its known calcic effects for many years, as well as its noncalchemic effects such as lesser known antimicrobial, immunological, airway remodeling and epigenetic regulation. In addition, it has been noted in recent years for its effects on the use of skeletal muscle strength and inhaled corticosteroid. Although the relationship between vitamin D and COPD is unclear yet, the possible association between D vitamine insufficiency and COPD pathogenesis, progression, exacerbations and comorbidities suggests that vitamin D supplementation may be beneficial in COPD. However, vitamin D supplementation has reported no exacerbation benefit for COPD patients in many studies, only a reduction in exacerbations in patients with severe D vitamin deficiency. In this review, we aimed to review the scientific literature on the role of vitamin D in COPD by focusing on epidemiological findings and underlying mechanisms.

Keywords: COPD; Vitamin D; VDR; Lung Diseases; Inflammation
REFERENCES:
  1. Global Initiative for Chronic Obstructive Lung Disease. Pocket Guide To Copd Diagnosis, Management, and Prevention A Guide for Health Care Professionals 2017 Edition. p.33. Available at: http://goldcopd.org/wp-content/uploads/2016/12/wms-GOLD-2017-Pocket-Guide.pdf Accessed November 1, 2017.
  2. GBD 2017 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392 (10159):1859-922. [Crossref] 
  3. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000-2016. Geneva: World Health Organization; 2018. p.41.
  4. Ulusal Hastalik Yuku Calismasi 2013. Ankara: Hacettepe Universitesi Nufus Etutleri Enstitusu; 2016. p.28. Erisim Adresi: http://www.hips.hacettepe.edu.tr/UHYCSunumu_06122016.pdf.
  5. Rossi A, Butorac-Petanjek B, Chilosi M, Cosio BG, Flezar M, Koulouris N, et al. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research-a consensus document from six scientific societies. Int J Chron Obstruct Pulmon Dis. 2017;12:2593-610. [Crossref]  [PubMed]  [PMC] 
  6. Gilbert CR, Arum SM, Smith CM. Vitamin D deficiency and chronic lung disease. Can Respir J. 2009;16(3):75-80. [Crossref]  [PubMed]  [PMC] 
  7. Gois PHF, Ferreira D, Olenski S, Seguro AC. Vitamin D and infectious diseases: simple bystander or contributing factor? Nutrients. 2017;9(7):651. [Crossref]  [PubMed]  [PMC] 
  8. Chambers ES, Hawrylowicz CM. The impact of vitamin D on regulatory T cells. Curr Allergy Asthma Rep. 2011;11(1):29-36. [Crossref]  [PubMed] 
  9. Bizzaro G, Antico A, Fortunato A, Bizzaro N. Vitamin D and autoimmune diseases: is vitamin D receptor (VDR) polymorphism the culprit? Isr Med Assoc J. 2017;19(7):438-43.
  10. Hansdottir S, Monick MM. Vitamin D effects on lung immunity and respiratory diseases. Vitam Horm. 2011;86:217-37. [Crossref]  [PubMed]  [PMC] 
  11. Kokturk N, Baha A, Oh YM, Young Ju J, Jones PW. Vitamin D deficiency: what does it mean for chronic obstructive pulmonary disease (COPD)? A compherensive review for pulmonologists. Clin Respir J. 2017;12(2):382-97. [Crossref]  [PubMed] 
  12. Ferrari R, Caram LMO, Tanni SE, Godoy I, Rupp de Paiva SA. The relationship between vitamin D status and exacerbation in COPD patients-a literature review. Respir Med. 2018;139:34-8. [Crossref]  [PubMed] 
  13. Janssens W, Decramer M, Mathieu C, Korf H. Vitamin D and chronic obstructive pulmonary disease: hype or reality? Lancet Respir Med. 2013;1(10):804-12. [Crossref] 
  14. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS One. 2012;7(6): e38934. [Crossref]  [PubMed]  [PMC] 
  15. El-Shafey BI, El Srougy HA. Does serum 25 hydroxy vitamin D level play a role in COPD? Egypt J Chest Dis Tuberc. 2014;63(1):43-7. [Crossref] 
  16. Cilingir BM, Gunbatar H. [Relationship between chronic obstructive pulmonary disease and levels of vitamin D]. Dicle Medical Journal. 2015;42(2):158-65. [Crossref] 
  17. Faerk G, Colak Y, Afzal S, Nordestgaard BG. Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study. Eur J Epidemiol. 2018;33(6):567-77. [Crossref]  [PubMed] 
  18. Zhu M, Wang T, Wang C, Ji Y. The association between vitamin D and COPD risk, severity, and exacerbation: an updated systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2597-607. [Crossref]  [PubMed]  [PMC] 
  19. Kentson M, Leanderson P, Jacobson P, Persson HL. The influence of disease severity and lifestyle factors on the peak annual 25(OH)D value of COPD patients. Int J Chron Obstruct Pulmon Dis. 2018;13:1389-98. [Crossref]  [PubMed]  [PMC] 
  20. Janssens W, Lehouck A, Carremans C, Bouillon R, Mathieu C, Decramer M. Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009;179(8):630-6. [Crossref]  [PubMed] 
  21. Lehouck A, Boonen S, Decramer M, Janssens W. COPD, bone metabolism, and osteoporosis. Chest. 2011;139(3):648-57. [Crossref]  [PubMed] 
  22. Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest. 1999;116(6):1616-24. [Crossref]  [PubMed] 
  23. Sabit R, Bolton CE, Edwards PH, Pettit RJ, Evans WD, McEniery CM, et al. Arterial stiffness and osteoporosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175(12):1259-65. [Crossref]  [PubMed] 
  24. Sin DD, Man JP, Man SF. The risk of osteoporosis in Caucasian men and women with obstructive airways disease. Am J Med. 2003;114(1):10-4. [Crossref] 
  25. Looker AC. Relationship between femur neck bone mineral density and prevalent chronic obstructive pulmonary disease (COPD) or COPD mortality in older non-Hispanic white adults from NHANES III. Osteoporos Int. 2014;25(3):1043-52. [Crossref]  [PubMed] 
  26. Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004,338(2):143-56. [Crossref]  [PubMed] 
  27. Finklea JD, Grossmann RE, Tangpricha V. Vitamin D and chronic lung disease: a review of molecular mechanisms and clinical studies. Adv Nutr. 2011;2(3):244-53. [Crossref]  [PubMed]  [PMC] 
  28. Rafiq R, Aleva FE, Schrumpf JA, Heijdra YF, Taube C, Daniels JM, et al. Prevention of exacerbations in patients with COPD and vitamin D deficiency through vitamin D supplementation (PRECOVID): a study protocol. BMC Pulm Med. 2015;15:106. [Crossref]  [PubMed]  [PMC] 
  29. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, Liao J, et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol. 2004;173(5):2909-12. [Crossref]  [PubMed] 
  30. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25 hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009;169(4): 384-90. [Crossref]  [PubMed]  [PMC] 
  31. Zhang LL, Gong J, Liu CT. Vitamin D with asthma and COPD: not a false hope? A systematic review and meta-analysis. Genet Mol Res. 2014;13(3):7607-16. [Crossref]  [PubMed] 
  32. Banerjee A, Panettieri R Jr. Vitamin D modulates airway smooth muscle function in COPD. Curr Opin Pharmacol. 2012;12(3):266-74. [Crossref]  [PubMed] 
  33. Solidoro P, Bellocchia M, Facchini F. The immunobiological and clinical role of vitamin D in obstructive lung diseases. Minerva Med. 2016;107:19-9.
  34. Hansdottir S, Monick MM, Lovan N, Powers L, Gerke A, Hunninghake GW. Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state. J Immunol. 2010;184(2):965-74. [Crossref]  [PubMed]  [PMC] 
  35. Berraies A, Hamzaoui K, Hamzaoui A. Link between vitamin D and airway remodeling. J Asthma Allergy. 2014;7:23-30. [Crossref]  [PubMed]  [PMC] 
  36. Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013;144(3):1026-32. [Crossref]  [PubMed] 
  37. Liu X, Nelson A, Wang X, Farid M, Gunji Y, Ikari J, et al. Vitamin D modulates prostaglandin E2 synthesis and degradation in human lung fibroblasts. Am J Respir Cell Mol Biol. 2014;50(1):40-50. [Crossref]  [PubMed] 
  38. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med. 2008;178(3):248-60. [Crossref]  [PubMed]  [PMC] 
  39. Dagouassat M, Gagliolo JM, Chrusciel S, Bourin MC, Duprez C, Caramelle P, et al. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts. Am J Respir Crit Care Med. 2013;187(7):703-14. [Crossref]  [PubMed] 
  40. Zhang J, Wu L, Qu JM, Bai CX, Merrilees MJ, Black PN. Pro-inflammatory phenotype of COPD fibroblasts not compatible with repair in COPD lung. J Cell Mol Med. 2012;16(7):1522-32. [Crossref]  [PubMed]  [PMC] 
  41. Foong RE, Bosco A, Jones AC, Gout A, Gorman S, Hart PH, et al. The effects of in utero vitamin D deficiency on airway smooth muscle mass and lung function. Am J Respir Cell Mol Biol. 2015;53(5):664-75. [Crossref]  [PubMed] 
  42. Kim SH, Pei QM, Jiang P, Yang M, Qian XJ, Liu J. Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment. Respir Res. 2017;18(1):7. [Crossref]  [PubMed]  [PMC] 
  43. Suzuki T. [Update on recent progress in vitamin D research. EldecalcitolR and Fall Prevention]. Clin Calcium. 2017;27(11):1595-600.
  44. Granic A, Hill TR, Davies K, Jagger C, Adamson A, Siervo M, et al. Vitamin D status, muscle strength and physical performance decline in very old adults: a prospective study. Nutrients. 2017;9(4):E379. [Crossref]  [PubMed]  [PMC] 
  45. Carson EL, Pourshahidi LK, Madigan SM, Baldrick FR, Kelly MG, Laird E, et al. Vitamin D status is associated with muscle strength and quality of life in patients with COPD: a seasonal prospective observation study. Int J Chron Obstruct Pulmon Dis. 2018;13:2613-22. [Crossref]  [PubMed]  [PMC] 
  46. Bone AE, Hepgul N, Kon S, Maddocks M. Sarcopenia and frailty in chronic respiratory disease. Chron Respir Dis. 2017;14(1):85-99. [Crossref]  [PubMed]  [PMC] 
  47. Byun MK, Cho EN, Chang J, Ahn CM, Kim HJ. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669-75. [Crossref]  [PubMed]  [PMC] 
  48. To M, Swallow EB, Akashi K, Haruki K, Natanek SA, Polkey MI, et al. Reduced HDAC2 in skeletal muscle of COPD patients. Respir Res. 2017;18(1):99. [Crossref]  [PubMed]  [PMC] 
  49. Hopkinson NS, Li KW, Kehoe A, Humphries SE, Roughton M, Moxham J, et al. Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008;87(2):385-90. [Crossref]  [PubMed] 
  50. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792-8. [Crossref]  [PubMed] 
  51. Semba RD, Chang SS, Sun K, Cappola AR, Ferrucci L, Fried LP. Serum 25-hydroxyvitamin D and pulmonary function in older disabled community-dwelling women. J Gerontol A Biol Sci Med Sci. 2012;67A(6):683-9. [Crossref]  [PubMed]  [PMC] 
  52. Monadi M, Heidari B, Asgharpour M, Firouzjahi A, Monadi M, Ghazi Mirsaied MA. Relationship between serum vitamin D and forced expiratory volume in patients with chronic obstructive pulmonary disease (COPD). Caspian J Intern Med. 2012;3(3):451-5.
  53. Park Y, Kim YS, Kang YA, Shin JH, Oh YM, Seo JB, et al. Relationship between vitamin D-binding protein polymorphisms and blood vitamin D level in Korean patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016;11: 731-8. [Crossref]  [PubMed]  [PMC] 
  54. Chishimba L, Thickett DR, Stockley RA, Wood AM. The vitamin D axis in the lung: a key role for vitamin D-binding protein. Thorax. 2010;65(5):456-62. [Crossref]  [PubMed] 
  55. Wang YL, Kong H, Xie WP, Wang H. Association of vitamin D-binding protein variants with chronic obstructive pulmonary disease: a meta-analysis. Genet Mol Res. 2015;14(3):10774-85. [Crossref]  [PubMed] 
  56. Kunisaki KM, Rector TS. Vitamin D and responses to inhaled fluticasone in severe chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:29-34. [Crossref]  [PubMed]  [PMC] 
  57. Zhang Y, Leung DY, Goleva E. Anti-inflammatory and corticosteroid enhancing actions of vitamin D in the monocytes of steroid resistant and steroid sensitive asthmatics. J Allergy Clin Immunol. 2014;133(6):1744-52.e1. [Crossref]  [PubMed]  [PMC] 
  58. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181(7):699-704. [Crossref]  [PubMed]  [PMC] 
  59. Mukherjee D, Parekh D, Dancer R, Ungurs M, Khiroya H, Turner AM. Can steroid insensitivity in COPD patients be restored using vitamin D? Thorax Dec. 2014;69:pA211-2. [Crossref] 
  60. Moosavi SAJ, Shoushtari MH. The effects of vitamin D supplementation on pulmonary function of chronic obstructive pulmonary disease patients, before and after clinical trial. Diseases. 2015;3(4):253-9. [Crossref]  [PubMed]  [PMC] 
  61. Said AF, Abd-Elnaeem EA. Vitamin D and chronic obstructive pulmonary disease. Egypt J Chest Dis Tuberc. 2015;64(1):67-73. [Crossref] 
  62. Rafiq R, Prins HJ, Boersma WG, Daniels JM, den Heijer M, Lips P, et al. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial. Int J Chron Obstruct Pulmon Dis. 2017;12:2583-92. [Crossref]  [PubMed]  [PMC] 
  63. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, et al. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med. 2012;156(2):105-14. [Crossref]  [PubMed] 
  64. Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, et al. Vitamin D supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial. Lancet Respir Med. 2015;3(2):120-30. [Crossref] 
  65. Pourrashid MH, Dastan F, Salamzadeh J, Eslaminejad A, Edalatifard M. Role of vitamin D replacement on health related quality of life in hospitalized patients with "Acute Exacerbation of Chronic Obstructive Pulmonary Disease". Iran J Pharm Res. 2018;17(2):801-10.

.: Up To Date

.: Process List

Login

 Forgot your password?

 New Registration  

Contact

Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş.

.: Address

Turkocagi Caddesi No:30 06520 Balgat / ANKARA
Phone: +90 312 286 56 56
Fax: +90 312 220 04 70
E-mail: info@turkiyeklinikleri.com

.: Manuscript Editing Department

Phone: +90 312 286 56 56/ 2
E-mail: yaziisleri@turkiyeklinikleri.com

.: English Language Redaction

Phone: +90 312 286 56 56/ 145
E-mail: tkyayindestek@turkiyeklinikleri.com

.: Marketing Sales-Project Department

Phone: +90 312 286 56 56/ 142
E-mail: reklam@turkiyeklinikleri.com

.: Subscription and Public Relations Department

Phone: +90 312 286 56 56/ 118
E-mail: abone@turkiyeklinikleri.com

.: Customer Services

Phone: +90 312 286 56 56/ 118
E-mail: satisdestek@turkiyeklinikleri.com

1. TERMS OF USE

1.1. To use the web pages with http://www.turkiyeklinikleri.com domain name or the websites reached through the sub domain names attached to the domain name (They will be collectively referred as "SITE"), please read the conditions below. If you do not accept these terms, please cease to use the "SITE." "SITE" owner reserves the right to change the information on the website, forms, contents, the "SITE," "SITE" terms of use anytime they want.

1.2. The owner of the "SITE" is Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. (From now on it is going to be referred as "Turkiye Klinikleri", shortly) and it resides at Turkocagi cad. No:30, 06520 Balgat Ankara. The services in the "SITE" are provided by "Turkiye Klinikleri."

1.3. Anyone accessing the "SITE" with or without a fee whether they are a natural person or a legal identity is considered to agree these terms of use. In this contract hereby, "Turkiye Klinikleri" may change the stated terms anytime. These changes will be published in the "SITE" periodically and they will be valid when they are published. Any natural person or legal identity benefiting from and reaching to the "SITE" are considered to be agreed to any change on hereby contract terms done by "Turkiye Klinikleri."

1.4. The "Terms of Use" hereby is published in the website with the last change on March 30th 2014 and the "SITE" is activated by enabling the access to everyone. The "Terms of Use" hereby is also a part of the any "USER Contract" was and/or will be done with the users using "Turkiye Klinikleri" services with or without a fee an inseparable.

2. DEFINITIONS

2.1. "SITE": A website offering different kind of services and context with a certain frame determined by "Turkiye Klinikleri" and it is accessible on-line on http://www.turkiyeklinikleri.com domain name and/or subdomains connected to the domain name.

2.2. USER: A natural person or a legal identity accessing to the "SITE" through online settings.

2.3. LINK: A link enabling to access to another website through the "SITE", the files, the context or through another website to the "SITE", the files and the context.

2.4. CONTEXT: Any visual, literary and auditory images published in the "Turkiye Klinikleri", "SITE" and/or any website or any accessible information, file, picture, number/figures, price, etc.

2.5. "USER CONTRACT": An electronically signed contract between a natural or a legal identity benefiting from special services "Turkiye Klinikleri" will provide and "Turkiye Klinikleri".

3. SCOPE OF THE SERVICES

3.1. "Turkiye Klinikleri" is completely free to determine the scope and quality of the services via the "SITE".

3.2. To benefit the services of "Turkiye Klinikleri" "SITE", the "USER" must deliver the features that will be specified by "Turkiye Klinikleri". "Turkiye Klinikleri" may change this necessity any time single-sided.

3.3. Not for a limited number, the services "Turkiye Klinikleri" will provide through the "SITE" for a certain price or for free are;

- Providing scientific articles, books and informative publications for health industry.

- Providing structural, statistical and editorial support to article preparation stage for scientific journals.

4. GENERAL PROVISIONS

4.1. "Turkiye Klinikleri" is completely free to determine which of the services and contents provided in the "SITE" will be charged.

4.2. People benefiting from the services provided by "Turkiye Klinikleri" and using the website can use the "SITE" only according to the law and only for personal reasons. Users have the criminal and civil liability for every process and action they take in the "SITE". Every USER agrees, declares and undertakes that they will not proceed by any function or action infringement of rights of "Turkiye Klinikleri"s and/or other third parties', they are the exclusive right holder on usage, processing, storage, made public and revealing any written, visual or auditory information reported to Turkiye Klinikleri" and/or "SITE" to the third parties. "USER" agrees and undertakes that s/he will not duplicate, copy, distribute, process, the pictures, text, visual and auditory images, video clips, files, databases, catalogs and lists within the "SITE", s/he will not be using these actions or with other ways to compete with "Turkiye Klinikleri", directly or indirectly.

4.3. The services provided and the context published within the "SITE" by third parties is not under the responsibility of "Turkiye Klinikleri", institutions collaborated with "Turkiye Klinikleri", "Turkiye Klinikleri" employee and directors, "Turkiye Klinikleri" authorized salespeople. Commitment to accuracy and legality of the published information, context, visual and auditory images provided by any third party are under the full responsibility of the third party. "Turkiye Klinikleri" does not promise and guarantee the safety, accuracy and legality of the services and context provided by a third party.

4.4. "USER"s cannot act against "Turkiye Klinikleri", other "USER"s and third parties by using the "SITE". "Turkiye Klinikleri" has no direct and/or indirect responsibility for any damage a third party suffered or will suffer regarding "USER"s actions on the "SITE" against the rules of the hereby "Terms of Use" and the law.

4.5. "USER"s accept and undertake that the information and context they provided to the "SITE" are accurate and legal. "Turkiye Klinikleri" is not liable and responsible for promising and guaranteeing the verification of the information and context transmitted to "Turkiye Klinikleri" by the "USER"s, or uploaded, changed and provided through the "SITE" by them and whether these information are safe, accurate and legal.

4.6. "USER"s agree and undertake that they will not perform any action leading to unfair competition, weakening the personal and commercial credit of "Turkiye Klinikleri" and a third party,  encroaching and attacking on personal rights within the "SITE" in accordance with the Turkish Commercial Code Law.

4.7. "Turkiye Klinikleri" reserves the right to change the services and the context within the "SITE"  anytime. "Turkiye Klinikleri" may use this right without any notification and timelessly. "USER"s have to make the changes and/or corrections "Turkiye Klinikleri" required immediately. Any changes and/or corrections that are required by "Turkiye Klinikleri", may be made by "Turkiye Klinikleri" when needed. Any harm, criminal and civil liability resulted or will result from changes and/or corrections required by "Turkiye Klinikleri" and were not made on time by the "USER"s belongs completely to the users.

4.8. "Turkiye Klinikleri" may give links through the "SITE" to other websites and/or "CONTEXT"s and/or folders that are outside of their control and owned and run by third parties. These links are provided for ease of reference only and do not hold qualification for support the respective web SITE or the admin or declaration or guarantee for the information inside. "Turkiye Klinikleri" does not hold any responsibility over the web-sites connected through the links on the "SITE", folders and context, the services or products on the websites provided through these links or their context.

4.9. "Turkiye Klinikleri" may use the information provided to them by the "USERS" through the "SITE" in line with the terms of the "PRIVACY POLICY" and "USER CONTRACT". It may process the information or classify and save them on a database. "Turkiye Klinikleri" may also use the USER's or visitor's identity, address, e-mail address, phone number, IP number, which sections of the "SITE" they visited, domain type, browser type, date and time information to provide statistical evaluation and customized services.

5. PROPRIETARY RIGHTS

5.1. The information accessed through this "SITE" or provided by the users legally and all the elements (including but not limited to design, text, image, html code and other codes) of the "SITE" (all of them will be called as studies tied to "Turkiye Klinikleri"s copyrights) belongs to "Turkiye Klinikleri". Users do not have the right to resell, process, share, distribute, display or give someone permission to access or to use the "Turkiye Klinikleri" services, "Turkiye Klinikleri" information and the products under copyright protection by "Turkiye Klinikleri". Within hereby "Terms of Use" unless explicitly permitted by "Turkiye Klinikleri" nobody can reproduce, process, distribute or produce or prepare any study from those under "Turkiye Klinikleri" copyright protection.

5.2. Within hereby "Terms of Use", "Turkiye Klinikleri" reserves the rights for "Turkiye Klinikleri" services, "Turkiye Klinikleri" information, the products associated with "Turkiye Klinikleri" copyrights, "Turkiye Klinikleri" trademarks, "Turkiye Klinikleri" trade looks or its all rights for other entity and information it has through this website unless it is explicitly authorized by "Turkiye Klinikleri".

6. CHANGES IN THE TERMS OF USE

"Turkiye Klinikleri" in its sole discretion may change the hereby "Terms of Use" anytime announcing within the "SITE". The changed terms of the hereby "Terms of Use" will become valid when they are announced. Hereby "Terms of Use" cannot be changed by unilateral declarations of users.

7. FORCE MAJEURE

"Turkiye Klinikleri" is not responsible for executing late or never of this hereby "Terms of Use", privacy policy and "USER Contract" in any situation legally taken into account as force majeure. Being late or failure of performance or non-defaulting of this and similar cases like this will not be the case from the viewpoint of "Turkiye Klinikleri", and "Turkiye Klinikleri" will not have any damage liability for these situations. "Force majeure" term will be regarded as outside of the concerned party's reasonable control and any situation that "Turkiye Klinikleri" cannot prevent even though it shows due diligence. Also, force majeure situations include but not limited to natural disasters, rebellion, war, strike, communication problems, infrastructure and internet failure, power cut and bad weather conditions.

8. LAW AND AUTHORISATION TO FOLLOW

Turkish Law will be applied in practicing, interpreting the hereby "Terms of Use" and managing the emerging legal relationships within this "Terms of Use" in case of finding element of foreignness, except for the rules of Turkish conflict of laws. Ankara Courts and Enforcement Offices are entitled in any controversy happened or may happen due to hereby contract.

9. CLOSING AND AGREEMENT

Hereby "Terms of Use" come into force when announced in the "SITE" by "Turkiye Klinikleri". The users are regarded to agree to hereby contract terms by using the "SITE". "Turkiye Klinikleri" may change the contract terms and the changes will be come into force by specifying the version number and the date of change on time it is published in the "SITE".

 

30.03.2014

Privacy Policy

We recommend you to read the terms of use below before you visit our website. In case you agree these terms, following our rules will be to your favor. Please read our Terms of Use thoroughly.

www.turkiyeklinikleri.com website belongs to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. and is designed in order to inform physicians in the field of health

www.turkiyeklinikleri.com cannot reach to user’s identity, address, service providers or other information. The users may send this information to the website through forms if they would like to. However, www.turkiyeklinikleri.com may collect your hardware and software information. The information consists of your IP address, browser type, operating system, domain name, access time, and related websites. www.turkiyeklinikleri.com cannot sell the provided user information (your name, e-mail address, home and work address, phone number) to the third parties, publish it publicly, or keep it in the website. Gathered information has a directing feature to be a source for the website’s visitor profile, reporting and promotion of the services.

www.turkiyeklinikleri.com uses the taken information:

-To enhance, improve and maintain the quality of the website

-To generate visitor’s profile and statistical data

-To determine the tendency of the visitors on using our website

-To send print publications/correspondences

-To send press releases or notifications through e-mail

-To generate a list for an event or competition

By using www.turkiyeklinikleri.com you are considered to agree that;

-Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. cannot be hold responsible for any user’s illegal and immoral behavior,

-Terms of use may change from time to time,

-It is not responsible for other websites’ contents it cannot control or the harms they may cause although it uses the connection they provided.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. may block the website to users in the following events:

-Information with wrong, incomplete, deceiving or immoral expressions is recorded to the website,

-Proclamation, advertisement, announcement, libelous expressions are used against natural person or legal identity,

-During various attacks to the website,

-Disruption of the website because of a virus.

Written, visual and audible materials of the website, including the code and the software are under protection by legal legislation.

Without the written consent of Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. the information on the website cannot be downloaded, changed, reproduced, copied, republished, posted or distributed.

All rights of the software and the design of the website belong to Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc.

Ortadoğu Advertisement Presentation Publishing Tourism Education Architecture Industry and Trade Inc. will be pleased to hear your comments about our terms of use. Please share the subjects you think may enrich our website or if there is any problem regarding our website.

info@turkiyeklinikleri.com